Literature DB >> 26119911

Silver nanoparticles embedded mesoporous SiO₂ nanosphere: an effective anticandidal agent against Candida albicans 077.

M Qasim1, Braj R Singh, A H Naqvi, P Paik, D Das.   

Abstract

Candida albicans is a diploid fungus that causes common infections such as denture stomatitis, thrush, urinary tract infections, etc. Immunocompromised patients can become severely infected by this fungus. Development of an effective anticandidal agent against this pathogenic fungus, therefore, will be very useful for practical application. In this work, Ag-embedded mesoporous silica nanoparticles (mSiO2@AgNPs) have successfully been synthesized and their anticandidal activities against C. albicans have been studied. The mSiO2@AgNPs nanoparticles (d ∼ 400 nm) were designed using pre-synthesized Ag nanoparticles and tetraethyl orthosilicate (TEOS) as a precursor for SiO2 in the presence of cetyltrimethyl ammonium bromide (CTAB) as an easily removable soft template. A simple, cost-effective, and environmentally friendly approach has been adopted to synthesize silver (Ag) nanoparticles using silver nitrate and leaf extract of Azadirachta indica. The mesopores, with size-equivalent diameter of the micelles (d = 4-6 nm), were generated on the SiO2 surface by calcination after removal of the CTAB template. The morphology and surface structure of mSiO2@AgNPs were characterized through x-ray diffraction (XRD), Fourier-transform infrared spectroscopy (FTIR), particle size analysis (PSA), atomic force microscopy (AFM), field emission scanning electron microscopy (FESEM), Brunauer-Emmett-Teller (BET) and high-resolution transmission electron microscopy (HRTEM). The HRTEM micrograph reveals the well-ordered mesoporous structure of the SiO2 sphere. The antifungal activities of mSiO2@AgNPs on the C. albicans cell have been studied through microscopy and are seen to increase with increasing dose of mSiO2@AgNPs, suggesting mSiO2@AgNPs to be a potential antifungal agent for C. albicans 077.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26119911     DOI: 10.1088/0957-4484/26/28/285102

Source DB:  PubMed          Journal:  Nanotechnology        ISSN: 0957-4484            Impact factor:   3.874


  7 in total

Review 1.  Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades?

Authors:  María Vallet-Regí; Ferdi Schüth; Daniel Lozano; Montserrat Colilla; Miguel Manzano
Journal:  Chem Soc Rev       Date:  2022-07-04       Impact factor: 60.615

Review 2.  Phytochemicals and Nano-Phytopharmaceuticals Use in Skin, Urogenital and Locomotor Disorders: Are We There?

Authors:  Mogana Rajagopal; Alok K Paul; Ming-Tatt Lee; Anabelle Rose Joykin; Choo-Shiuan Por; Tooba Mahboob; Cristina C Salibay; Mario S Torres; Maria Melanie M Guiang; Mohammed Rahmatullah; Rownak Jahan; Khoshnur Jannat; Polrat Wilairatana; Maria de Lourdes Pereira; Chooi Ling Lim; Veeranoot Nissapatorn
Journal:  Plants (Basel)       Date:  2022-05-08

Review 3.  Nanoparticles as Potential Novel Therapies for Urinary Tract Infections.

Authors:  Sofía V Sánchez; Nicolás Navarro; Johanna Catalán-Figueroa; Javier O Morales
Journal:  Front Cell Infect Microbiol       Date:  2021-04-19       Impact factor: 5.293

4.  Novel fabrication of SiO2/Ag nanocomposite by gamma irradiated Fusarium oxysporum to combat Ralstonia solanacearum.

Authors:  Amira G Zaki; Yasmeen A Hasanien; Gharieb S El-Sayyad
Journal:  AMB Express       Date:  2022-02-28       Impact factor: 3.298

5.  Environmentally sustainable route to SiO2@Au-Ag nanocomposites for biomedical and catalytic applications.

Authors:  Kanti Sapkota; Prerna Chaudhary; Sung Soo Han
Journal:  RSC Adv       Date:  2018-09-05       Impact factor: 4.036

6.  Synergetic Antimicrobial Effect of Silver Nanoparticles Conjugated with Iprodione against Valsa mali.

Authors:  Tao Li; Weidong Huang; Haibing Yu
Journal:  Materials (Basel)       Date:  2022-07-25       Impact factor: 3.748

Review 7.  Highlights in Mesoporous Silica Nanoparticles as a Multifunctional Controlled Drug Delivery Nanoplatform for Infectious Diseases Treatment.

Authors:  Gabriela Corrêa Carvalho; Rafael Miguel Sábio; Tais de Cássia Ribeiro; Andreia Sofia Monteiro; Daniela Vassalo Pereira; Sidney José Lima Ribeiro; Marlus Chorilli
Journal:  Pharm Res       Date:  2020-09-07       Impact factor: 4.200

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.